Bruce Stephens
Well-Known Member
- Relationship to Diabetes
- Type 1
Kind of wonder how robust the study design was, when they had to change the statistical analysis methodology post facto:
Yes, the small size is disappointing. But in the abstract the design is elegant, I think: give people 12 bottles (4 each of statins, placebo, empty) and have them use them in a predetermined random order.Really, given the small size of the study, I wonder whether it was actually powered to be very informative at all.
It doesn't seem that there was anything much in it to strngly suggest that subjects were seeing anything other than a nocebo effect ...
I think the assumption is that given a month of something different most people would get the difference. I agree it's quite possible there'll be exceptions so this might well miss some problems, but it matches what most people say, I think: that quite quickly after stopping taking them they feel the problems easing.But they are assuming that as soon as you stop taking the statin the unpleasant effects go away instantly. Didn't work like that for me.